ESR1 and breast cancer: We propose a direct genomic mechanism of antagonism to ESR1 activity in the uterus by PGR through inhibiting Esr1 and Greb1. In breast cancer cells, PGR is known to regulate some target genes in opposite directions through intermingled chromatin binding with ESR1.